Peripheral nerve hyperexcitability syndromes.

Area of Science:

• Neurology
• Clinical Electrophysiology

Background:

• Peripheral nerve hyperexcitability (PNH) syndromes are categorized into primary (neuromyotonia, cramp-fasciculation syndrome, Morvan's syndrome) and secondary types.
• Primary PNH syndromes manifest with widespread muscle twitching and stiffness, potentially involving central nervous system symptoms in Morvan's syndrome.
• Secondary PNH syndromes are associated with peripheral nervous system diseases and often detected incidentally.

Purpose of the Study:

• To review the classification, clinical manifestations, diagnostic approaches, and management strategies for peripheral nerve hyperexcitability syndromes.
• To highlight the diagnostic utility of electrophysiological findings in PNH.
• To discuss the evolving understanding of PNH pathogenesis, including autoimmune and genetic factors.

Main Methods:

• Literature review of PNH syndromes, focusing on clinical features, electrophysiology, etiology, and treatment.
• Analysis of diagnostic criteria and electrophysiological markers such as myokymic and neuromyotonic discharges.
• Examination of etiological associations, including immune-mediated, genetic, and toxic factors.

Main Results:

• PNH syndromes present with diverse symptoms like muscle twitching, stiffness, cramps, and autonomic dysfunction.
• Electromyography is crucial for diagnosis, revealing characteristic myokymic and neuromyotonic discharges.
• Primary PNH pathogenesis increasingly linked to voltage-gated potassium channel autoimmunity, alongside genetic and toxic factors.

Conclusions:

• PNH syndromes encompass a spectrum of disorders with distinct clinical and electrophysiological profiles.
• Accurate diagnosis relies on integrating clinical findings with electrophysiological evidence.
• Management involves symptomatic treatment, immune modulation when indicated, and addressing underlying etiologies, with a growing focus on autoimmune mechanisms.